Nishiyama Yoshihiro, Yamamoto Yuka, Fukunaga Kotaro, Takinami Hiroyuki, Iwado Yasuyoshi, Satoh Katashi, Ohkawa Motoomi
Department of Radiology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
J Nucl Med. 2006 Oct;47(10):1571-6.
67Ga scintigraphy has been used for years in sarcoidosis for diagnosis and the extent of the disease. However, little information is available on the comparison of 18F-FDG PET and 67Ga scintigraphy in the assessment of sarcoidosis. The purpose of this study was to compare the uptake of 18F-FDG and 67Ga in the evaluation of pulmonary and extrapulmonary involvement in patients with sarcoidosis.
Eighteen patients with sarcoidosis were examined. 18F-FDG PET was performed at 1 h after injection of 185-200 MBq 18F-FDG. 67Ga whole-body planar and thoracic SPECT images were acquired 72 h after injection of 111 MBq 67Ga. We evaluated 18F-FDG and 67Ga uptake visually and semiquantitatively using standardized uptake values (SUVs) and the ratio of lesion to normal lumbar spine (L/N ratio), respectively. The presence of pulmonary and extrapulmonary lesions was evaluated histopathologically or by the radiologic findings.
Five patients had only pulmonary lesions, 12 patients had both pulmonary and extrapulmonary lesions, and 1 patient had only an extrapulmonary lesion. Both 67Ga planar and SPECT images detected 17 of 21 (81%) clinically observed pulmonary sites. The mean +/- SD of the L/N ratio was 1.97 +/- 1.09. 67Ga planar images detected 15 of 31 (48%) clinically observed extrapulmonary sites. The mean +/- SD of the L/N ratio was 1.17 +/- 0.33. 18F-FDG PET detected all 21 (100%) clinically observed pulmonary sites. The mean +/- SD of the SUV was 7.40 +/- 2.48. 18F-FDG PET detected 28 of 31 (90%) clinically observed extrapulmonary sites. The mean +/- SD of the SUV was 5.90 +/- 2.75.
The results of this clinical study suggest that 18F-FDG PET can detect pulmonary lesions to a similar degree as 67Ga scintigraphy. However, 18F-FDG PET appears to be more accurate and contributes to a better evaluation of extrapulmonary involvement in sarcoidosis patients.
多年来,67Ga闪烁显像一直用于结节病的诊断及病情评估。然而,关于18F-FDG PET与67Ga闪烁显像在结节病评估中的比较,相关信息较少。本研究的目的是比较18F-FDG和67Ga在结节病患者肺内及肺外受累情况评估中的摄取情况。
对18例结节病患者进行检查。注射185 - 200 MBq 18F-FDG后1小时行18F-FDG PET检查。注射111 MBq 67Ga后72小时采集67Ga全身平面及胸部SPECT图像。我们分别使用标准化摄取值(SUV)和病变与正常腰椎的比值(L/N比值)对18F-FDG和67Ga摄取进行视觉和半定量评估。通过组织病理学或影像学检查结果评估肺内及肺外病变的存在情况。
5例患者仅有肺部病变,12例患者既有肺部病变又有肺外病变,1例患者仅有肺外病变。67Ga平面及SPECT图像检测到21个临床观察到的肺部病灶中的17个(81%)。L/N比值的均值±标准差为1.97±1.09。67Ga平面图像检测到31个临床观察到的肺外病灶中的15个(48%)。L/N比值的均值±标准差为1.17±0.33。18F-FDG PET检测到所有21个(100%)临床观察到的肺部病灶。SUV的均值±标准差为7.40±2.48。18F-FDG PET检测到31个临床观察到的肺外病灶中的28个(90%)。SUV的均值±标准差为5.90±2.75。
本临床研究结果表明,18F-FDG PET检测肺部病变的程度与67Ga闪烁显像相似。然而,18F-FDG PET似乎更准确,有助于更好地评估结节病患者的肺外受累情况。